Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
Add more filters










Publication year range
1.
J Anesth ; 33(6): 628-635, 2019 12.
Article in English | MEDLINE | ID: mdl-31473808

ABSTRACT

PURPOSE: Prolonged propofol infusion induces skeletal muscle damage. However, it is well known that the lipid emulsion that is the solvent of propofol causes various types of tissue damage via lipid peroxidation, and that propofol, conversely, has an anti-lipid peroxidative effect. The purpose of this study was to determine whether propofol or the lipid emulsion is the cause of muscle damage following prolonged administration. METHODS: Rats were divided into four groups: NI group (no intervention), Cath group (venous catheter insertion only), Prop group (1% propofol (Maruishi) intravenous infusion at 10 mg/kg/h), and Lipid group (10% Lipofundin® intravenous infusion at 100 mg/kg/h) (n = 10, each group). 1% Propofol (Maruishi) or Lipofundin was infused at 1 mL/kg/h for 72 h. The solvent of 1% propofol (Maruishi) is a 10% lipid emulsion. Lipofundin consists of 50% long-chain triacylglycerols and 50% medium-chain triacylglycerols, similar to the propofol solvent. Plasma concentrations of creatine kinase and myoglobin, superoxide production level, and 4-hydroxynonenal and malondialdehyde expression in the gastrocnemius muscle were evaluated 72 h after the interventions. RESULTS: Plasma concentrations of creatine kinase and myoglobin in the Lipid group were significantly higher than those in the other three groups. The superoxide production level, and 4-hydroxynonenal and malondialdehyde expression in the Lipid group were also significantly higher than in the other three groups. CONCLUSION: Lipofundin induces skeletal muscle damage via lipid peroxidation, and 1% propofol (Maruishi) conversely suppresses the muscle damage via antioxidant effects.


Subject(s)
Lipid Peroxidation/drug effects , Muscle, Skeletal/drug effects , Phospholipids/toxicity , Propofol/toxicity , Sorbitol/toxicity , Anesthetics, Intravenous/administration & dosage , Animals , Antioxidants/metabolism , Drug Combinations , Infusions, Intravenous , Male , Malondialdehyde/metabolism , Propofol/administration & dosage , Rats , Rats, Wistar
2.
Cell Death Differ ; 26(11): 2371-2385, 2019 Nov.
Article in English | MEDLINE | ID: mdl-30804470

ABSTRACT

Various types of cell death, including apoptosis, necrosis, necroptosis, and ferroptosis, are induced in renal tubular epithelial cells following exposure to environmental stresses and toxicants such as osmotic stress, ischemia/reperfusion injury, cisplatin, and cadmium. This is known to cause renal dysfunction, but the cellular events preceding stress-induced cell death in renal tubules are not fully elucidated. The activin receptor-like kinase (ALK) 4/5, also known as activin-transforming growth factor (TGF) ß receptor, is involved in stress-induced renal injury. We, therefore, studied the role of ALK4/5 signaling in HK-2 human proximal tubular epithelial cell death induced by cisplatin, cadmium, hyperosmotic stress inducer, sorbitol, and the ferroptosis activator, erastin. We found that ALK4/5 signaling is involved in cadmium- and erastin-induced cell death, but not sorbitol- or cisplatin-induced apoptotic cell death. Cadmium exposure elevated the level of phosphorylated Smad3, and treatment with the ALK4/5 kinase inhibitors, SB431542 or SB505124, suppressed cadmium-induced HK-2 cell death. Cadmium-induced cell death was attenuated by siRNA-mediated ALK4 or Smad3 silencing, or by treatment with SIS3, a selective inhibitor of TGFß1-dependent Smad3 phosphorylation. Furthermore, ALK4/5 signaling activated Akt signaling to promote cadmium-induced HK-2 cell death. In contrast, siRNA-mediated Inhibin-bA silencing or treatment with TGFß1 or activin A had little effect on cadmium-induced HK-2 cell death. On the other hand, treatment with SB431542 or SB505124 attenuated erastin-induced ferroptosis by hyperactivating Nrf2 signaling in HK-2 cells. These results suggest that blockade of ALK4/5 signaling protects against cadmium- and erastin-induced HK-2 cell death via Akt and Nrf2 signaling pathways, respectively.


Subject(s)
Activin Receptors, Type I/metabolism , Cadmium/toxicity , Cell Death/physiology , Epithelial Cells/metabolism , Piperazines/toxicity , Receptor, Transforming Growth Factor-beta Type I/metabolism , Activin Receptors, Type I/antagonists & inhibitors , Activin Receptors, Type I/genetics , Activins/metabolism , Apoptosis/genetics , Apoptosis/physiology , Cell Line , Cisplatin/toxicity , Ferroptosis/drug effects , Glutathione/metabolism , Humans , Kidney Tubules, Proximal/cytology , Kidney Tubules, Proximal/metabolism , NF-E2-Related Factor 2/metabolism , Necroptosis/drug effects , Necrosis/pathology , Proto-Oncogene Proteins c-akt/metabolism , RNA Interference , RNA, Small Interfering/genetics , Receptor, Transforming Growth Factor-beta Type I/antagonists & inhibitors , Receptor, Transforming Growth Factor-beta Type I/genetics , Signal Transduction/drug effects , Sorbitol/toxicity , Transforming Growth Factor beta1/metabolism
3.
J Cell Physiol ; 228(11): 2222-31, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23625794

ABSTRACT

FUsed in Sarcoma/Translocated in LipoSarcoma (FUS/TLS or FUS) has been linked to several biological processes involving DNA and RNA processing, and has been associated with multiple diseases, including myxoid liposarcoma and amyotrophic lateral sclerosis (ALS). ALS-associated mutations cause FUS to associate with stalled translational complexes called stress granules under conditions of stress. However, little is known regarding the normal role of endogenous (non-disease linked) FUS in cellular stress response. Here, we demonstrate that endogenous FUS exerts a robust response to hyperosmolar stress induced by sorbitol. Hyperosmolar stress causes an immediate re-distribution of nuclear FUS to the cytoplasm, where it incorporates into stress granules. The redistribution of FUS to the cytoplasm is modulated by methyltransferase activity, whereas the inhibition of methyltransferase activity does not affect the incorporation of FUS into stress granules. The response to hyperosmolar stress is specific, since endogenous FUS does not redistribute to the cytoplasm in response to sodium arsenite, hydrogen peroxide, thapsigargin, or heat shock, all of which induce stress granule assembly. Intriguingly, cells with reduced expression of FUS exhibit a loss of cell viability in response to sorbitol, indicating a prosurvival role for endogenous FUS in the cellular response to hyperosmolar stress.


Subject(s)
Cytoplasmic Granules/metabolism , Hypertonic Solutions/pharmacology , RNA-Binding Protein FUS/metabolism , Stress, Physiological/drug effects , Animals , Cell Death/drug effects , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cell Survival/drug effects , Cytoplasmic Granules/drug effects , HEK293 Cells , HeLa Cells , Humans , Methylation/drug effects , Mice , Sorbitol/pharmacology , Sorbitol/toxicity
4.
Am J Med ; 126(3): 264.e9-24, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23321430

ABSTRACT

BACKGROUND: Sodium polystyrene sulfonate (Kayexalate; Sanofi-Aventis, Paris, France) is a cation-exchange resin routinely used in the management of hyperkalemia. However, its use has been associated with colonic necrosis and other fatal gastrointestinal adverse events. Although the addition of sorbitol to sodium polystyrene sulfonate preparations was previously believed to be the cause of gastrointestinal injury, recent reports have suggested that sodium polystyrene sulfonate itself may be toxic. Our objective was to systematically review case reports of adverse gastrointestinal events associated with sodium polystyrene sulfonate use. METHODS: MEDLINE (1948 to July 2011), EMBASE (1980 to July 2011), Cochrane Central Register of Controlled Trials (CENTRAL) (1993 to July 27, 2011), bibliographies of identified articles, and websites of relevant drug agencies and professional associations in the United States and Canada were reviewed to identify eligible reports of adverse gastrointestinal events associated with sodium polystyrene sulfonate use. Causality criteria of the World Health Organization causality assessment system were applied to each report. RESULTS: Thirty reports describing 58 cases (41 preparations containing sorbitol and 17 preparations without sorbitol) of adverse events were identified. The colon was the most common site of injury (n=44; 76%), and transmural necrosis (n=36; 62%) was the most common histopathologic lesion reported. Mortality was reported in 33% of these cases due to gastrointestinal injury. CONCLUSIONS: Sodium polystyrene sulfonate use, both with and without sorbitol, may be associated with fatal gastrointestinal injury. Physicians must be cognizant of the risk of these adverse events when prescribing this therapy for the management of hyperkalemia.


Subject(s)
Cation Exchange Resins/adverse effects , Gastrointestinal Diseases/chemically induced , Polystyrenes/adverse effects , Cation Exchange Resins/administration & dosage , Cation Exchange Resins/toxicity , Colonic Diseases/chemically induced , Drug Therapy, Combination , Female , Gastrointestinal Diseases/pathology , Gastrointestinal Tract/pathology , Humans , Male , Middle Aged , Necrosis/chemically induced , Polystyrenes/administration & dosage , Polystyrenes/toxicity , Sorbitol/administration & dosage , Sorbitol/adverse effects , Sorbitol/toxicity
5.
J Cardiovasc Pharmacol ; 61(2): 160-5, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23222311

ABSTRACT

Atherosclerosis is a major cause of death in the Western World. It is known that Lipofundin 20% induces atherosclerotic lesions, whereas ozone at low doses has been satisfactorily used in the prevention of oxidative stress-associated pathologies, such as coronary artery diseases. The aim of the present work was to evaluate the effects of ozone therapy on Lipofundin-induced atherosclerotic lesions in New Zealand White rabbits. Ozone (1 mg), mixed with oxygen as passive carrier, was administered by rectal insufflation during 15 sessions in 5 weeks. Then, the animals were intravenously treated with 2 mL/kg of Lipofundin, daily during 8 days. Animals were euthanized and eosin and hematoxylin staining was used for aortic histopathological analysis. The biomarkers of oxidative stress and lipid profile in serum were determined by spectrophotometric techniques. The results demonstrated that ozone induced inhibitory effects on aortic lesions formation. On the other hand, a reduction of biomolecular damage and an increase of antioxidant systems were observed at the end of the experiment. The serum lipids profiles were not modified after only 1 cycle of ozone treatment. Our results reinforced the hypotheses that antioxidant effects induced by ozone in the context of atherosclerosis demonstrate the antiatherogenic properties of the gas in the experimental conditions of this study.


Subject(s)
Antioxidants/pharmacology , Atherosclerosis/prevention & control , Oxidative Stress/drug effects , Ozone/pharmacology , Animals , Antioxidants/administration & dosage , Antioxidants/metabolism , Aorta/drug effects , Aorta/pathology , Disease Models, Animal , Drug Combinations , Lipids/blood , Male , Oxygen/administration & dosage , Ozone/administration & dosage , Phospholipids/toxicity , Rabbits , Sorbitol/toxicity , Spectrophotometry
7.
Biomaterials ; 32(36): 9908-24, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21959011

ABSTRACT

Here we report an accelerated gene transfer through a polysorbitol-based osmotically active transporter (PSOAT) that shows several surprising results through interesting mechanisms. The nano-sized and well-complexed PSOAT/DNA particles are less toxic, stable at serum and show no aggregation after lyophilization due to their polysorbitol backbone. The transfection is remarkably accelerated both in vitro and in vivo, presumably due to a transporter mechanism of PSOAT in spite of possibility of reduction of transfection by many hydroxyl groups in the transporter. PSOAT possesses a transporter mechanism owing to its polysorbitol backbone, which enhances cellular uptake by exerting polysorbitol transporter activity, thus accelerates gene transfer to cells because transfection ability of PSOAT is drastically reduced in the presence of a cyclooxygenase (COX)-2-specific inhibitor, which we have reported as an inhibitor of the transporter to cells. Moreover, the gene expression is found to be enhanced by hyperosmotic activity and buffering capacity due to polysorbitol and polyethylenimine backbone of PSOAT, respectively. The polysorbitol in PSOAT having polyvalency showed more efficiency in accelerating gene transfer capability than monovalent sorbitol. The above interesting mechanisms display PSOAT as a remarkably potential system to deliver therapeutic (small interfering RNA) and diagnostic agents for effective treatment of cancer.


Subject(s)
Gene Transfer Techniques , Polyesters/chemistry , Polyethyleneimine/analogs & derivatives , Sorbitol/chemistry , Aerosols/administration & dosage , Animals , Biological Transport , Cell Death , Cell Line, Tumor , DNA/metabolism , Electrophoresis, Agar Gel , Freeze Drying , Green Fluorescent Proteins/metabolism , Humans , Luciferases/metabolism , Lung/metabolism , Mice , Mice, Inbred C57BL , Microscopy, Electron, Transmission , Osmosis , Particle Size , Polyesters/chemical synthesis , Polyesters/toxicity , Polyethyleneimine/chemical synthesis , Polyethyleneimine/chemistry , Polyethyleneimine/toxicity , Serum , Sorbitol/chemical synthesis , Sorbitol/toxicity , Static Electricity , Transfection
8.
Toxicol Appl Pharmacol ; 237(2): 232-6, 2009 Jun 01.
Article in English | MEDLINE | ID: mdl-19341753

ABSTRACT

Aquaporin (AQP) 9 is a member of the aquaglyceroporin subfamily of AQPs in the transfer of water and small solutes such as glycerol and arsenite. It is well recognized that arsenic toxicity is associated with intracellular accumulation of this metalloid. In the present study, we examined the contribution of AQP9 to the uptake of inorganic arsenite, thereby increasing arsenic-induced cytotoxicity in primary mouse hepatocytes. Pretreatment with sorbitol as a competitive inhibitor of AQP9 and siRNA-mediated knockdown of AQP9 resulted in a significant decrease of arsenite uptake in the cell and its cytotoxicity. Furthermore, overexpression of AQP9 in HEK293 cells led to the enhancement of intracellular arsenic concentration, resulting in enhanced cytotoxicity after arsenite exposure. These results suggest that AQP9 is a channel to define arsenite sensitivity in primary mouse hepatocytes.


Subject(s)
Aquaporins/metabolism , Arsenites/metabolism , Enzyme Inhibitors/metabolism , Hepatocytes/metabolism , Sodium Compounds/metabolism , Animals , Aquaporins/genetics , Arsenic/chemistry , Arsenic/metabolism , Arsenic/toxicity , Arsenites/toxicity , Cells, Cultured , Environmental Pollutants/metabolism , Environmental Pollutants/toxicity , Enzyme Inhibitors/toxicity , Gene Expression Regulation , Hepatocytes/cytology , Humans , Male , Mice , Mice, Inbred C57BL , Molecular Structure , Sodium Compounds/toxicity , Sorbitol/chemistry , Sorbitol/metabolism , Sorbitol/toxicity
9.
Front Biosci ; 12: 1308-17, 2007 Jan 01.
Article in English | MEDLINE | ID: mdl-17127383

ABSTRACT

The induction of cell death in human erythroleukemic cells (K562) by sorbitol shows the typical apoptotic changes in ultrastructural morphology, including blebbing, chromatin condensation and nuclear membrane breakdown. Using a cytofluorimetric approach, we found that sorbitol induced production of reactive oxygen species (ROS) followed by DNA fragmentation in leukemic cells. In this study, we investigated effect of curcumin and rosmarinic acid on cell viability in three different cell lines: erythroleukemia K562, papillary NPA, and anaplastic ARO thyroid cancers. Curcumin was able to induce apoptosis in a concentration- and time dependent manner in three cell lines, while rosmarinic acid was less effective on this process. To examine this possibility in cellular system, this study evaluated the capacities of both compounds acting as antioxidant inhibiting sorbitol-induced apoptosis. K562, NPA and ARO cells were pre-incubated with 25 microM rosmarinic acid to allow the uptake and then the cell lines were treated with 1 M sorbitol. Afterwards, the cells were subjected to agarose gel electrophoresis to assess the DNA fragmentation. In conclusion, the antioxidant activity of rosmarinic acid is able to inhibit sorbitol-induced apoptosis.


Subject(s)
Antioxidants/pharmacology , Apoptosis/drug effects , Cinnamates/pharmacology , DNA Fragmentation/drug effects , Depsides/pharmacology , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Cell Line, Tumor , Curcumin/pharmacology , Humans , K562 Cells , Osmotic Pressure , Sorbitol/antagonists & inhibitors , Sorbitol/toxicity , Rosmarinic Acid
10.
Arch Microbiol ; 183(3): 224-7, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15714295

ABSTRACT

Glyoxalase I is a ubiquitous enzyme that catalyzes the conversion of methylglyoxal, a toxic 2-oxoaldehyde derived from glycolysis, to S-D-lactoylglutathione. The activity of glyoxalase I in the fission yeast Schizosaccharomyces pombe was increased by osmotic stress induced by sorbitol. However, neither the mRNA levels of its structural gene nor its protein levels increased under the same conditions. Cycloheximide blocked the induction of glyoxalase I activity in cells exposed to osmotic stress. In addition, glyoxalase I activity was increased in stress-activated protein kinase-deficient mutants (wis1 and spc1). We present evidence for the post-translational regulation of glyoxalase I by osmotic stress in the fission yeast.


Subject(s)
Gene Expression Regulation, Fungal , Lactoylglutathione Lyase/metabolism , RNA, Fungal/metabolism , RNA, Messenger/metabolism , Schizosaccharomyces/enzymology , Blotting, Northern , Blotting, Western , Cycloheximide/pharmacology , Fungal Proteins/metabolism , Lactoylglutathione Lyase/genetics , Mitogen-Activated Protein Kinase Kinases/genetics , Mutation , Osmotic Pressure , Protein Kinases/genetics , Protein Synthesis Inhibitors/pharmacology , RNA, Fungal/genetics , RNA, Messenger/genetics , Schizosaccharomyces/genetics , Schizosaccharomyces pombe Proteins/genetics , Sorbitol/toxicity
11.
Cell Death Differ ; 11(5): 512-26, 2004 May.
Article in English | MEDLINE | ID: mdl-14752512

ABSTRACT

AlphaA- and alphaB-crystallins are distinct antiapoptotic regulators. Regarding the antiapoptotic mechanisms, we have recently demonstrated that alphaB-crystallin interacts with the procaspase-3 and partially processed procaspase-3 to repress caspase-3 activation. Here, we demonstrate that human alphaA- and alphaB-crystallins prevent staurosporine-induced apoptosis through interactions with members of the Bcl-2 family. Using GST pulldown assays and coimmunoprecipitations, we demonstrated that alpha-crystallins bind to Bax and Bcl-X(S) both in vitro and in vivo. Human alphaA- and alphaB-crystallins display similar affinity to both proapoptotic regulators, and so are true with their antiapoptotic ability tested in human lens epithelial cells, human retina pigment epithelial cells (ARPE-19) and rat embryonic myocardium cells (H9c2) under treatment of staurosporine, etoposide or sorbitol. Two prominent mutants, R116C in alphaA-crystallin and R120G, in alphaB-crystallin display much weaker affinity to Bax and Bcl-X(S). Through the interaction, alpha-crystallins prevent the translocation of Bax and Bcl-X(S) from cytosol into mitochondria during staurosporine-induced apoptosis. As a result, alpha-crystallins preserve the integrity of mitochondria, restrict release of cytochrome c, repress activation of caspase-3 and block degradation of PARP. Thus, our results demonstrate a novel antiapoptotic mechanism for alpha-crystallins.


Subject(s)
Apoptosis/drug effects , Proto-Oncogene Proteins c-bcl-2/metabolism , alpha-Crystallin A Chain/metabolism , alpha-Crystallin B Chain/metabolism , Animals , Caspases/metabolism , Cells, Cultured , Cytochromes c/metabolism , Cytosol/metabolism , Epithelial Cells/metabolism , Etoposide/toxicity , Genes, bcl-2/physiology , Humans , Mitochondria/metabolism , Mutation/genetics , Myocytes, Cardiac/metabolism , Protein Transport/physiology , Rats , Sorbitol/toxicity , Staurosporine/toxicity , bcl-2-Associated X Protein , bcl-X Protein
12.
Cell Signal ; 14(10): 839-48, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12135705

ABSTRACT

Cytosolic phospholipase A(2) (cPLA(2)) is an enzyme involved in the formation of proinflammatory mediators by catalyzing the release of arachidonic acid, thereby mediating eicosanoid biosynthesis. Using HaCaT keratinocytes as a model system, we present experimental evidence that in these cells, cPLA(2) is constitutively phosphorylated and that the degree of phosphorylation dramatically increases in cells under hyperosmotic stress induced by sorbitol. In parallel, a rapid release of arachidonic acid followed by prostaglandin E(2) formation was detected. Elucidating the mechanism of cPLA(2) upregulation, we observed that it is mediated via epidermal growth factor receptor (EGFR) activation, since tyrphostin AG1478, a selective inhibitor of EGFR tyrosine kinase, completely inhibited cPLA(2) phosphorylation. Furthermore, addition of PD98059, which is an inhibitor of MEK1 activation, but not of SB203580, which is an inhibitor of p38 stress kinase, inhibited cPLA(2) phosphorylation, indicating that the ras-raf-MEK cascade is the major signalling pathway involved in cPLA(2) phosphorylation. In addition, depletion of the cells from intracellular calcium does not prevent sorbitol-elicited cPLA(2) phosphorylation, suggesting that this process is independent of the presence of calcium. Together, our results demonstrate that hyperosmotic stress phosphorylates cPLA(2) in human keratinocytes by an EGFR-mediated process.


Subject(s)
Drug Eruptions/enzymology , ErbB Receptors/metabolism , Keratinocytes/drug effects , Keratinocytes/enzymology , Osmotic Pressure/drug effects , Phospholipases A/metabolism , Phospholipids/metabolism , Stress, Physiological/enzymology , Arachidonic Acid/metabolism , Calcium/deficiency , Cell Compartmentation/drug effects , Cell Compartmentation/physiology , Cell Line, Transformed , Cell Nucleus/drug effects , Cell Nucleus/enzymology , Dinoprostone/metabolism , Drug Eruptions/physiopathology , Enzyme Inhibitors/pharmacology , Epidermal Growth Factor/metabolism , ErbB Receptors/drug effects , Humans , MAP Kinase Kinase 1 , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/physiology , Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/drug effects , Mitogen-Activated Protein Kinases/metabolism , Phospholipases A/drug effects , Phosphorylation/drug effects , Phosphotransferases/antagonists & inhibitors , Phosphotransferases/metabolism , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Serine-Threonine Kinases/metabolism , Sorbitol/toxicity , Stress, Physiological/chemically induced , Stress, Physiological/physiopathology , Tyrosine/metabolism , p38 Mitogen-Activated Protein Kinases
13.
Cancer Biother Radiopharm ; 13(5): 395-401, 1998 Oct.
Article in English | MEDLINE | ID: mdl-10851431

ABSTRACT

Anti-anaemic drug, ferric-sorbitol-citrate complex (FSC), inhibit tumour cell growth through the mechanisms which are complex and not entirely understood. The probable mechanisms of described effects of iron is iron-induced oxidative stress of the treated cells. Hence, the effects of FSC on HeLa cell growth in vitro were compared with the biological activity of one of the major mediators of the oxygen free radicals--aldehyde 4-hydroxinonenal (HNE), to see if the effects of FSC and of HNE resemble each other. Impaired proliferative ability and DNA synthesis of HeLa cells was observed after treatment with anti-anaemic drug FSC for 24 hours. After treatment with FSC and culturing of HeLa cells in fresh medium for 24 or 96 hours the cells did not proliferate at all, DNA synthesis was transiently recovered and then diminished again. HNE blocked cell proliferation during the time the aldehyde was present in culture and 24 h later. Afterwards, the cells proliferated as control non-treated cells. HNE did not inhibit DNA synthesis during treatment, but intensity of 3H-thymidine incorporation was lower after preincubation. Thus, both FSC and HNE interfere with the basic mechanisms of the cell growth regulation, while antitumour activity of FSC resembles, but does not necessarily include iron induced lipid peroxidation.


Subject(s)
Aldehydes/toxicity , Cell Division/drug effects , Citric Acid/toxicity , DNA/drug effects , Ferric Compounds/toxicity , Sorbitol/toxicity , DNA/biosynthesis , Drug Combinations , HeLa Cells , Humans , Kinetics , Lipid Peroxidation , Thymidine/metabolism , Time Factors
14.
J Med Chem ; 40(5): 684-94, 1997 Feb 28.
Article in English | MEDLINE | ID: mdl-9057855

ABSTRACT

Accumulation of intracellular sorbitol, the reduced product of glucose, catalyzed by aldose reductase (AR) (EC 1.1.1.21), is thought to be the cause of the development of diabetic complications. Our attention is focused on finding compounds which inhibit AR without significantly inhibiting aldehyde reductase (ALR) (EC 1.1.1.2). The uracil or 2,4-dioxoimidazolidine skeleton having the benzothiazolyl or 4-chloro-3-nitrophenyl group as an aryl part indicated not only extremely high AR inhibitory activity but also AR selectivity. The ratio of IC50(ALR)/IC50(AR) of 3-[(5-chlorobenzothiazol-2-yl)methyl]-1,2,3,4-tetrahydro-2,4- dioxopyrimidine-1-acetic acid (47d) was more than 17 500. The uracil skeleton with the benzothiazolyl moiety seemed to be the best combination for selective AR inhibition.


Subject(s)
Acetates/chemical synthesis , Aldehyde Reductase/antagonists & inhibitors , Enzyme Inhibitors/chemical synthesis , Imidazoles/chemical synthesis , Pyrimidinones/chemical synthesis , Thiazoles/chemical synthesis , Acetates/chemistry , Acetates/pharmacology , Aldehyde Reductase/metabolism , Animals , Benzothiazoles , Diabetes Complications , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Humans , Imidazoles/chemistry , Imidazoles/pharmacology , Kidney/enzymology , Lens, Crystalline/enzymology , Magnetic Resonance Spectroscopy , Models, Molecular , Molecular Structure , Phthalazines/chemistry , Phthalazines/pharmacology , Pyrimidinones/chemistry , Pyrimidinones/pharmacology , Rats , Sorbitol/pharmacology , Sorbitol/toxicity , Structure-Activity Relationship , Thiazoles/chemistry , Thiazoles/pharmacology
16.
Eur Urol ; 29(3): 355-61, 1996.
Article in English | MEDLINE | ID: mdl-8740023

ABSTRACT

We compared morphological changes in the heart, brain, liver and kidneys after giving 100 ml/kg of 5 irrigating fluids by intravenous infusion to 30 rabbits. Glycine 1.5% and 1.0%, both with ethanol 1% as a tracer for absorption, received the highest scores for tissue swelling and were sometimes followed by focal necrosis and an inflammatory cell reaction in subendocardial areas of the heart. Three rabbits died shortly after infusion of glycine 1.5% + ethanol 1%, the deaths being preceded by bradycardia and an irregular cardiac rhythm. This solution also lowered the intracellular potassium and chlorine content as shown by X-ray microanalysis of myocardial cells. Mannitol 3% + ethanol 1% produced the most favorable outcome in our evaluation, with the lowest scores for tissue swelling, while sorbitol 2% + mannitol 1% and normal saline took intermediate positions.


Subject(s)
Brain/drug effects , Heart/drug effects , Kidney/drug effects , Liver/drug effects , Animals , Brain/pathology , Chlorine/metabolism , Diuretics, Osmotic/administration & dosage , Diuretics, Osmotic/toxicity , Drug Synergism , Electrocardiography/drug effects , Electron Probe Microanalysis , Ethanol/administration & dosage , Ethanol/toxicity , Glycine/administration & dosage , Glycine/toxicity , Heart Rate/drug effects , Infusions, Intravenous , Kidney/pathology , Liver/pathology , Male , Mannitol/administration & dosage , Mannitol/toxicity , Myocardium/pathology , Necrosis , Potassium/metabolism , Rabbits , Random Allocation , Solvents/toxicity , Sorbitol/administration & dosage , Sorbitol/toxicity , Therapeutic Irrigation/adverse effects
17.
Urology ; 46(6): 821-4, 1995 Dec.
Article in English | MEDLINE | ID: mdl-7502423

ABSTRACT

OBJECTIVES: A higher mortality probably due to myocardial infarction has been demonstrated after transurethral resection of the prostate (TURP) compared with open prostatectomy. We used an experimental model system to study the possibility that this difference might be due to cardiotoxic effects of two events that frequently occur during TURP, namely, dissemination of electrolyte-free irrigating fluid and release of prostate tissue substances by electrocutting. METHODS: Cardiomyocytes were isolated from male Sprague-Dawley rats. Cell morphology and viability were examined repeatedly during 3 hours of incubation. Control experiments were compared with 34 preparations mixed with one of five different irrigating fluids and with 28 preparations mixed with a prostate extract, either from the same rat or from patients undergoing TURP. RESULTS: Most irrigating fluids reduced the viability of the myocytes. The fraction of viable cells in the incubation mixture averaged 83% (glycine 1.5%), 88% (glycine 1.5% plus ethanol 1%), 92% (glycine 2.2%), 92% (mannitol 3% plus ethanol 1%), and 99% (sorbitol 2% plus mannitol 1%) of that found in the respective control incubations. In contrast, the prostate extracts did not decrease the viability of the cardiomyocytes. Extract from the rats even seemed to have a trophic effect. CONCLUSIONS: Our results show that electrolyte-free irrigating fluids but not prostate extracts have mild cardiotoxic properties. This opens up the possibility that fluid absorption during TURP has a devitalizing effect on the heart.


Subject(s)
Ethanol/toxicity , Glycine/toxicity , Heart/drug effects , Mannitol/toxicity , Myocardium/cytology , Prostate/chemistry , Sorbitol/toxicity , Therapeutic Irrigation/adverse effects , Tissue Extracts/pharmacology , Animals , Cell Survival/drug effects , Cells, Cultured , Male , Rats , Rats, Sprague-Dawley
18.
Toxicol Lett ; 78(3): 183-8, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7624888

ABSTRACT

The effects of N-benzyl-D-glucamine dithiocarbamate (BGD), diethyldithiocarbamate (DDTC), and N-p-hydroxymethylbenzyl-D-glucamine dithiocarbamate (HBGD) on the enzymatic activities in mice were studied. The mice were given i.v. injections of these chelating agents (1 mmol/kg) and 3 h later the activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyltranspeptidase (gamma-GTP), alkaline phosphatase (ALP), leucine aminopeptidase (LAP), and cholinesterase (ChE) in the liver, kidney, and blood were determined. These enzymatic activities were little changed by treatment with these chelating agents. Cadmium (Cd) administration markedly decreased the activities of AST and ALT in the liver and kidney and greatly increased these enzymatic activities in blood. The changes in the enzymatic activities by treatment with Cd were prevented by injection of BGD (1 mmol/kg). These results indicate that BGD, DDTC, and HBGD were not toxic to the liver or kidney of mice and that BGD treatment protected against the acute hepatic and renal toxicity induced by Cd.


Subject(s)
Cadmium/toxicity , Chelating Agents/toxicity , Kidney/drug effects , Liver/drug effects , Thiocarbamates/toxicity , Alanine Transaminase/blood , Alanine Transaminase/metabolism , Alkaline Phosphatase/blood , Alkaline Phosphatase/metabolism , Analysis of Variance , Animals , Aspartate Aminotransferases/blood , Aspartate Aminotransferases/metabolism , Cadmium/administration & dosage , Cadmium/blood , Cholinesterases/blood , Cholinesterases/metabolism , Ditiocarb/administration & dosage , Ditiocarb/metabolism , Ditiocarb/pharmacology , Injections, Intravenous , Kidney/enzymology , Leucyl Aminopeptidase/blood , Leucyl Aminopeptidase/metabolism , Liver/enzymology , Male , Mice , Reference Standards , Sorbitol/administration & dosage , Sorbitol/analogs & derivatives , Sorbitol/blood , Sorbitol/toxicity , Thiocarbamates/administration & dosage , Thiocarbamates/blood , gamma-Glutamyltransferase/blood , gamma-Glutamyltransferase/metabolism
19.
Invest Radiol ; 23 Suppl 1: S84-7, 1988 Sep.
Article in English | MEDLINE | ID: mdl-3198369

ABSTRACT

Vascular pain caused by contrast media (CM) cannot be quantified by subjective patient reports or manifest pain reactions in experimental animals. Therefore, conditioned taste aversion (CTA), a psychopharmacological method, was used in double-blind femoral arteriography in rats to compare a new nonionic monomeric CM, ioxilan, with iohexol, iopamidol (all at 350 mgI/mL) and 22% sorbitol. A chronically implanted femoral artery catheter was used to inject 0.2 mL/kg body weight. By measuring the intake of water laced with the flavor that thirsty rats had learned to associate with the injection, the degree of aversion, assumed proportional to pain, was determined. Ioxilan (690 mOsm) produced the least pain, followed by iopamidol (810 mOsm), iohexol (844 mOsm) and sorbitol (1410 mOsm). Since all test substances are highly and similarly hydrophilic and nonionic, the intensity of vascular pain must depend on solution osmolality, rather than on chemotoxicity or ionicity. Compounds of the lowest osmolality, ig, ioxilan, elicit the least vascular pain.


Subject(s)
Contrast Media/toxicity , Iohexol/analogs & derivatives , Pain/chemically induced , Animals , Conditioning, Psychological , Female , Iohexol/toxicity , Iopamidol/toxicity , Osmolar Concentration , Rats , Rats, Inbred Strains , Sorbitol/toxicity , Taste
20.
Invest Radiol ; 23 Suppl 1: S114-7, 1988 Sep.
Article in English | MEDLINE | ID: mdl-3143685

ABSTRACT

Hypertonic and hypotonic contrast media and/or solutions were injected intracerebrally and into the subarachnoid space of rats, and the effects on the central nervous system (CNS) were investigated. Additionally, rabbits were injected intracisternally with nonionic contrast media that were either isotonic or hypertonic to the cerebrospinal fluid, and their behavior was observed. Both hypertonic and hypotonic contrast media and/or control solutions caused CNS depression, but not excitation. Even slight hypertonicity affected motor coordination. The sedating effect of nonionic contrast media, when given in the large doses customary in in vivo experiments, can mask their inherent epileptogenicity and give a false impression of a high safety margin.


Subject(s)
Behavior, Animal/drug effects , Brain/drug effects , Contrast Media/toxicity , Mannitol/toxicity , Sorbitol/toxicity , Animals , Female , Male , Osmolar Concentration , Rabbits , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...